Abstract
Amor and colleagues previously developed chimeric antigen receptor (CAR) T cells that can target and eliminate senescent cells. The utility of these senolytic CAR T cells is now expanded to show that they can combat age-related metabolic dysfunction, and that they can be used prophylactically and have effects that persist for months, thus opening the door to the development of long-term senolytic approaches.
Original language | English (US) |
---|---|
Pages (from-to) | 284-286 |
Number of pages | 3 |
Journal | Nature Aging |
Volume | 4 |
Issue number | 3 |
DOIs |
|
State | Published - Mar 2024 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© Springer Nature America, Inc. 2024.
PubMed: MeSH publication types
- Journal Article